The future of nicotine delivery: Technology, policy and public health

  • K. E. Warner
  • J. Slade
  • D. T. Sweanor
Conference paper

Abstract

In developed countries, concerns about the health effects of smoking have led to the introduction of new methods of delivering nicotine. The tobacco industry is producing devices made to look like cigarettes in which radically different techniques are used to deliver nicotine to smokers and which reduce smokers’ exposure to some of the poisons in conventional cigarette smoke. The industry’s intent is to keep smokers dependent on nicotine and the industry’s products. In contrast, the pharmaceutical industry has developed nicotine replacement products with the purpose of helping smokers to wean themselves off nicotine altogether. Given a potentially enormous market for less hazardous cigarette substitutes, however, it is possible that an aggressive competition might soon develop between the tobacco and pharmaceutical industries to serve a large population of long-term nicotine addicts. In this paper, we describe some of the new techniques, discuss policy issues raised by this newly emerging market and consider implications for public health.

Keywords

Toxicity Glycerine Nicotine Marketing Carbon Monoxide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Benowitz, N.L. & Gourlay, S.G. (1997) Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy.J. Am. Coll. Cardiol.,29, 1422 – 1431PubMedCrossRefGoogle Scholar
  2. Benowitz, N.L. & Henningfield, J.E. (1994) Establishing a nicotine threshold for addiction.New Engl. J. Med.,331, 123 – 125PubMedCrossRefGoogle Scholar
  3. Davis, R.M. & Slade, J. (1993) Back to the future—with electrically powered cigarettes.Tobacco Control,2, 11 – 12Google Scholar
  4. Department of Health and Human Services (1989)Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General (DHHS Publication No. (CDC) 89-8411), Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Washington DC: Government Printing OfficeGoogle Scholar
  5. Kozlowski, L.T. & Pillitteri, J.L. (1996) Compensation for nicotine by smokers of lower yield cigarettes. In: US Department of Health and Human Services,The FTC Cigarette Test Method for Determining Tar, Nicotine, and Carbon Monoxide Yields of US Cigarettes. Report of the NCI Expert Committee (NIH Publication No. 96–4028), Public Health Service, National Institutes of Health. Bethesda, Maryland: National Cancer Institute, pp. 161–172Google Scholar
  6. Leischow, S.J., Stine, C.M., Nordbrock, J., Marriott, J. & Zobrist, R.H. (1996) One week trial of oral transmucosal nicotine for smoking cessation (Abstract).J Addictive Dis.,15, 146Google Scholar
  7. Pauly, J.L., Streck, R.J. & Cummings, K.M. (1995) US patents shed light on Eclipse and future cigarettes.Tobacco Control,4, 261 – 265CrossRefGoogle Scholar
  8. R J. Reynolds Tobacco Company (1988)Chemical and Biological Studies of New Cigarette Prototypes that Heat Instead of Burn Tobacco, Winston-Salem, North CarolinaGoogle Scholar
  9. Slade, J. (1989) The tobacco epidemic: Lessons from history.J. Psychoactive Drugs,21, 281 – 291PubMedGoogle Scholar
  10. Slade, J. (1989) The tobacco epidemic: Lessons from history.J. Psychoactive Drugs,21, 281 – 291PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2000

Authors and Affiliations

  • K. E. Warner
    • 1
  • J. Slade
    • 2
  • D. T. Sweanor
    • 3
  1. 1.University of MichiganAnn ArborUSA
  2. 2.Robert Wood Johnson Medical SchoolNew BrunswickUSA
  3. 3.Nonsmokers’ Rights AssociationOttawaCanada

Personalised recommendations